Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Busque
D G Gilliland

Blood

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Blood|July 1, 1996
Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with ageL Busque, R Mio, J Mattioli, et al.
Blood|January 1, 1995
Clonality in juvenile chronic myelogenous leukemiaL Busque, D G Gilliland, J T Prchal, et al.
Blood|April 6, 2001
ARG tyrosine kinase activity is inhibited by STI571K Okuda, E Weisberg, D G Gilliland, et al.
Blood|June 17, 1998
Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2)T S Ross, O A Bernard, R Berger, et al.
Blood|February 27, 2001
Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABLS Li, S Gillessen, M H Tomasson, et al.
Blood|February 7, 1998
Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sourcesB M Léonard, F Hétu, L Busque, et al.
Blood|January 7, 1998
CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteinsM Carroll, S Ohno-Jones, S Tamura, et al.
Blood|December 9, 1998
Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemiaM L Loh, L B Silverman, M L Young, et al.
Blood|February 25, 1999
TEL/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitorM H Tomasson, I R Williams, R Hasserjian, et al.
Blood|November 24, 2001
The TEL/PDGFbetaR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathwaysD W Sternberg, M H Tomasson, M Carroll, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Blood|July 1, 1996
Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with ageL Busque, R Mio, J Mattioli, et al.
Blood|January 1, 1995
Clonality in juvenile chronic myelogenous leukemiaL Busque, D G Gilliland, J T Prchal, et al.
Blood|April 6, 2001
ARG tyrosine kinase activity is inhibited by STI571K Okuda, E Weisberg, D G Gilliland, et al.
Blood|June 17, 1998
Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2)T S Ross, O A Bernard, R Berger, et al.
Blood|February 27, 2001
Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABLS Li, S Gillessen, M H Tomasson, et al.
Blood|February 7, 1998
Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sourcesB M Léonard, F Hétu, L Busque, et al.
Blood|January 7, 1998
CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteinsM Carroll, S Ohno-Jones, S Tamura, et al.
Blood|December 9, 1998
Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemiaM L Loh, L B Silverman, M L Young, et al.
Blood|February 25, 1999
TEL/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitorM H Tomasson, I R Williams, R Hasserjian, et al.
Blood|November 24, 2001
The TEL/PDGFbetaR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathwaysD W Sternberg, M H Tomasson, M Carroll, et al.
Pageof 2